These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone. Nesti C; Pardini C; Barachini S; D'Alessandro D; Siciliano G; Murri L; Petrini M; Vaglini F Brain Res; 2011 Jan; 1367():94-102. PubMed ID: 20854799 [TBL] [Abstract][Full Text] [Related]
23. Dopamine neurons in a simple GDNF-treated meso-striatal organotypic co-culture model. Schatz DS; Kaufmann WA; Saria A; Humpel C Exp Brain Res; 1999 Aug; 127(3):270-8. PubMed ID: 10452214 [TBL] [Abstract][Full Text] [Related]
24. Effects of combined BDNF and GDNF treatment on cultured dopaminergic midbrain neurons. Sautter J; Meyer M; Spenger C; Seiler RW; Widmer HR Neuroreport; 1998 Apr; 9(6):1093-6. PubMed ID: 9601674 [TBL] [Abstract][Full Text] [Related]
25. Stage-dependent vulnerability of fetal mesencephalic neuroprogenitors towards dopaminergic neurotoxins. Sabolek M; Mieskes I; Lenk T; Lehmensiek V; Hermann A; Schwarz J; Storch A Neurotoxicology; 2008 Jul; 29(4):714-21. PubMed ID: 18513801 [TBL] [Abstract][Full Text] [Related]
26. Overexpression of heme oxygenase-1 protects dopaminergic neurons against 1-methyl-4-phenylpyridinium-induced neurotoxicity. Hung SY; Liou HC; Kang KH; Wu RM; Wen CC; Fu WM Mol Pharmacol; 2008 Dec; 74(6):1564-75. PubMed ID: 18799798 [TBL] [Abstract][Full Text] [Related]
27. Interactions of cyclic adenosine monophosphate, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor treatment on the survival and growth of postnatal mesencephalic dopamine neurons in vitro. Lara J; Kusano K; House S; Gainer H Exp Neurol; 2003 Mar; 180(1):32-45. PubMed ID: 12668147 [TBL] [Abstract][Full Text] [Related]
28. Glial cell line-derived neurotrophic factor stimulates the morphological differentiation of cultured ventral mesencephalic calbindin- and calretinin-expressing neurons. Widmer HR; Schaller B; Meyer M; Seiler RW Exp Neurol; 2000 Jul; 164(1):71-81. PubMed ID: 10877917 [TBL] [Abstract][Full Text] [Related]
29. Role of glial cell derived neurotrophic factor in the protective effect of smilagenin on rat mesencephalic dopaminergic neurons damaged by MPP+. Zhang Y; Xia Z; Hu Y; Orsi A; Rees D FEBS Lett; 2008 Mar; 582(6):956-60. PubMed ID: 18298955 [TBL] [Abstract][Full Text] [Related]
30. Bone morphogenetic proteins: neurotrophic roles for midbrain dopaminergic neurons and implications of astroglial cells. Jordan J; Böttner M; Schluesener HJ; Unsicker K; Krieglstein K Eur J Neurosci; 1997 Aug; 9(8):1699-709. PubMed ID: 9283824 [TBL] [Abstract][Full Text] [Related]
31. Differential effects of growth/differentiation factor 5 and glial cell line-derived neurotrophic factor on dopaminergic neurons and astroglia in cultures of embryonic rat midbrain. Wood TK; McDermott KW; Sullivan AM J Neurosci Res; 2005 Jun; 80(6):759-66. PubMed ID: 15880784 [TBL] [Abstract][Full Text] [Related]
32. A non-peptidyl neurotrophic small molecule for midbrain dopaminergic neurons. Lin LF; Rubin LL; Xu M J Neurochem; 2004 Jun; 89(6):1387-95. PubMed ID: 15189341 [TBL] [Abstract][Full Text] [Related]
33. Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment. Han BS; Hong HS; Choi WS; Markelonis GJ; Oh TH; Oh YJ J Neurosci; 2003 Jun; 23(12):5069-78. PubMed ID: 12832530 [TBL] [Abstract][Full Text] [Related]
34. Protein from chromaffin granules promotes survival of mesencephalic dopaminergic neurons by an EGF-receptor ligand-mediated mechanism. Krieglstein K; Unsicker K J Neurosci Res; 1997 Apr; 48(1):18-30. PubMed ID: 9086178 [TBL] [Abstract][Full Text] [Related]
35. Effect of GDNF on differentiation of cultured ventral mesencephalic dopaminergic and non-dopaminergic calretinin-expressing neurons. Schaller B; Andres RH; Huber AW; Meyer M; Pérez-Bouza A; Ducray AD; Seiler RW; Widmer HR Brain Res; 2005 Mar; 1036(1-2):163-72. PubMed ID: 15725414 [TBL] [Abstract][Full Text] [Related]
36. An in vitro model of human dopaminergic neurons derived from embryonic stem cells: MPP+ toxicity and GDNF neuroprotection. Zeng X; Chen J; Deng X; Liu Y; Rao MS; Cadet JL; Freed WJ Neuropsychopharmacology; 2006 Dec; 31(12):2708-15. PubMed ID: 17109014 [TBL] [Abstract][Full Text] [Related]
37. Qualitative and quantitative re-evaluation of epidermal growth factor-ErbB1 action on developing midbrain dopaminergic neurons in vivo and in vitro: target-derived neurotrophic signaling (Part 1). Iwakura Y; Zheng Y; Sibilia M; Abe Y; Piao YS; Yokomaku D; Wang R; Ishizuka Y; Takei N; Nawa H J Neurochem; 2011 Jul; 118(1):45-56. PubMed ID: 21517852 [TBL] [Abstract][Full Text] [Related]
38. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease. Cunningham LA; Su C Exp Neurol; 2002 Apr; 174(2):230-42. PubMed ID: 11922664 [TBL] [Abstract][Full Text] [Related]
39. Neuroprotective mechanism of glial cell line-derived neurotrophic factor on dopamine neurons: role of antioxidation. Chao CC; Lee EH Neuropharmacology; 1999 Jun; 38(6):913-6. PubMed ID: 10465695 [TBL] [Abstract][Full Text] [Related]
40. PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP+ in mesencephalic neurons and by MPTP in a mouse model of Parkinson's disease. Visanji NP; Orsi A; Johnston TH; Howson PA; Dixon K; Callizot N; Brotchie JM; Rees DD FASEB J; 2008 Jul; 22(7):2488-97. PubMed ID: 18364399 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]